• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Hepatitis A Virus Antigen (Inactivated)
    5 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Avaxim 160 U
    Medici
    RX
    not in the basket chart
    Avaxim 160 U

    Hepatitis A Virus Antigen (Inactivated) 160 U / 0.5 ml.
    PREFILLED SYRINGE (susp. for inject): 1.
    I.M. Prim. vaccinat: 0.5 ml. Booster: Aft.
    6 mths.
    Active immunizat. against hepatit. A
    virus in adults and adolescents from age
    15 yrs.
    C/I: Fever, acute illness, chron. progress.
    dis. (postpone vaccinat.), hypersens. to
    one of the compon./prev. inject. See lit.

    Avaxim 80 U Pediatric
    Medici
    RX
    not in the basket chart
    Avaxim 80 U Pediatric

    Hepatitis A Virus Antigen (Inactivated) 80 U / 0.5 ml.
    SUSP. FOR INJECT. (single dose prefilled
    syringe): 1. Prim. vaccinat: 0.5 ml.
    Booster within 6-8 mths. foll. initial dose.
    I.M. in deltoid. See lit.
    SUSP. FOR INJECT. (multidose vial): 10 x
    0.5 ml. As above
    Active immunizat. against hepatit. A
    virus in child 12 mths-15 yrs (inclus.).
    C/I: Hypersens. to active ingred.,
    neomycin, polysorbate, foll. prev. inject.
    Feber, acute/chron. evolv. dis. See lit.

    Havrix 1440
    GSK
    RX
    not in the basket chart
    Havrix 1440

    Hepatitis A Vaccine. Hepatitis A Virus Antigen (Inactivated) 1440 E.L.U/ml.
    VIAL: 1×1ml. Primary
    immunis. consists of a single dose
    given IM. This provides anti-HAV
    antibody. for at least one y. See lit.
    Act. immunisation against infec. caused
    by Hepatit. A virus.
    The vaccine is particul. indic. for those
    at incr. risk of infec. or transmis.
    C/I: Hypersens.to the act. subst. or to
    neomycin (present at traces).

    Havrix 720 Junior
    GSK
    RX
    not in the basket chart
    Havrix 720 Junior

    Hepatitis A Vaccine. Hepatitis A Virus Antigen (Inactivated) 720 E.L.U / 0.5 ml.
    MONODOSE VIAL.: 1 x 0.5 ml/ vial.
    Child./adolesc. (1-15 yrs.) Prim.
    immunis. consists of a single dose
    given IM. This provides anti-HAV
    antibod. for at least 1 year. In order to
    obtain more persist. immune., for at
    least 10 yrs., a booster dose is recom.
    btwn. 6- 12 mnths. after prim. immun.
    See lit.
    Active immune. against HAV infect. from
    1 year up to and include.15 yrs. of age.
    The vaccine is partic. indic.for those at
    incr. risk of infect. or transmiss.
    C/I: Hypersens.

    Vaqta
    MSD
    RX
    not in the basket chart
    Vaqta

    Hepatitis Vaccines. Hepatitis A Virus Antigen (Inactivated) 25 U/0.5 ml, 50 U/ml.
    Adult formulat: 50 IU/1 ml; Ped./adolesc.
    formulat: 25 IU/0.5 ml.
    VIAL + SYRINGE: 1 + 1. 18 yrs and over:
    Single 1.0 ml (~50U) dose at elected
    date; booster dose 1.0 ml (~50U) 6
    mths. later. Ped./Adolesc. 2-17 yrs:
    Single 0.5 ml (~25U) dose at elected
    date; booster dose 0.5 ml (~25U) 6-18
    mths. later. See lit.
    Active pre-exposure proph. hepatit. A in 2
    yrs and older. Prim. immunizat. to be
    given at least 2 wks. prior to expect.
    exposure to HIV (see lit.).
    C/I: Hypersens.

    CLOSE